RXNT - FQHC GTM Playbook

Data-Driven Outreach for Federally Qualified Health Centers

Generated by Blueprint GTM Intelligence | January 2026

The Blueprint Methodology

Jordan Crawford is the founder of Blueprint GTM, a system that uses government regulatory data, competitive intelligence, and velocity signals to identify prospects in pain. Unlike traditional SDR outreach that relies on growth proxies and generic value props, Blueprint messages mirror exact situations using verifiable public data.

This playbook contains 4 data-driven plays for RXNT targeting Federally Qualified Health Centers (FQHCs) with revenue cycle and operational challenges.

Company Context

RXNT provides award-winning, integrated healthcare software for medical practices. Their full suite platform includes EHR (Electronic Health Records), E-Prescribing, Practice Management, Medical Billing/RCM, Patient Portal, and Scheduling—all cloud-based and fully integrated.

Core Value Proposition: Affordable ($118/month per provider starting), intuitive, and fully-integrated healthcare IT platform that eliminates the complexity of managing multiple disconnected systems.

Target Market: Small to medium-sized independent medical practices, including FQHCs, medical billing companies, and multi-specialty practices seeking cost-effective alternatives to expensive legacy systems like eClinicalWorks, athenahealth, and Epic.

ICP for This Playbook: Federally Qualified Health Centers (FQHCs) with 2,000-15,000 annual patients, facing revenue cycle inefficiencies, grant reporting burden, or system integration challenges.

The Old Way (Generic SDR Outreach)

Subject: Quick Question about Community Health Center Hi Sarah, I noticed on LinkedIn that your health center recently expanded to serve more patients. Congrats on the growth! I wanted to reach out because we work with FQHCs like Alliance Health and Community Care Partners to help with EHR and billing challenges. Our platform offers integrated EHR, practice management, and billing capabilities. We've helped health centers achieve better revenue cycle performance and streamline operations. Would you have 15 minutes next week to explore how we might be able to help your organization? Best, Generic SDR

Why This Fails:

Generic trigger: "recently expanded" is assumed, not proven with data
No specific pain: "billing challenges" could mean anything
Feature dump: Lists capabilities without connecting to actual problems
High friction: Asks for 15-minute meeting before demonstrating value
No verification: Recipient can't verify any claims

The New Way (Hard Data + Non-Obvious Insights)

Blueprint messages use verifiable government data (HRSA UDS reports, CMS databases, state licensing boards) to mirror exact situations and create non-obvious syntheses the prospect doesn't already have.

Two Message Types:

PQS (Pain-Qualified Segment): Uses data to prove the prospect is experiencing a painful situation right now (7.0-8.4 score = Strong PQS)
TRUE PVP (Permissionless Value Proposition): Delivers complete actionable information they can use immediately without meeting (8.5+ score required)

This playbook contains: 0 TRUE PVPs, 4 Strong PQS messages (scores: 7.2-8.0/10)

FQHC Pain Plays

Play #1: High-Growth Revenue Cycle Strain Strong (8.0/10)

Target: FQHCs that experienced >15% Y/Y patient volume growth while maintaining high grant revenue dependency (>40%), indicating revenue cycle processing bottlenecks.

Why It Works: This message synthesizes patient growth velocity with revenue mix stagnation to identify billing inefficiency. The prospect knows they're growing, but doesn't calculate per-patient revenue trends—the "$362k missed revenue" framing creates financial urgency that resonates with Executive Directors thinking about budget sustainability.

DATA SOURCES:

HRSA UDS Reports - TOTAL_PATIENTS, MEDICAL_REVENUE, GRANT_REVENUE, TOTAL_REVENUE fields
Confidence: 95% (pure government data, audited annually)
Update Frequency: Annual

Subject: Revenue per patient dropped Your 2024 UDS shows $1,022 medical revenue per patient, down from $1,150 in 2023. With 2,832 patients, that's $362k in missed revenue vs prior efficiency. How are you addressing the gap?

CALCULATION WORKSHEET: CLAIM 1: "$1,022 medical revenue per patient, down from $1,150 in 2023" - Source: HRSA UDS Section 9A (MEDICAL_REVENUE) ÷ Section 5 (TOTAL_PATIENTS) - 2024: $2,894,304 / 2,832 patients = $1,022 per patient - 2023: $2,760,000 / 2,400 patients = $1,150 per patient - Confidence: 95% CLAIM 2: "$362k in missed revenue vs prior efficiency" - Formula: (2024 patients × 2023 per-patient rate) - 2024 actual - Calculation: (2,832 × $1,150) - $2,894,304 = $362,496 - Confidence: 90% (assumes 2023 efficiency is achievable baseline) Verification: Download your FQHC's UDS report, compare year-over-year

Buyer Critique Score: 8.0/10

Situation Recognition: 8/10 - Revenue per patient declining is specific and concerning
Data Credibility: 9/10 - UDS audited data, verifiable calculation
Insight Value: 8/10 - "$362k missed" frames problem financially (budget-relevant)
Effort to Reply: 7/10 - Open-ended but easy to engage
Emotional Resonance: 8/10 - $362k is material to FQHC operating budgets

Play #2: Grant Dependency Risk Strong (8.0/10)

Target: FQHCs with medical revenue <45% of total (below median 55%), indicating billing capture inefficiencies and excess grant reliance.

Why It Works: Connects grant dependency to billing capture rate using benchmark comparison. The non-obvious synthesis is the link between high Medicaid/uninsured payer mix (78%) and below-benchmark medical revenue percentage—they should be billing MORE efficiently given their payer mix, not less. The "excess grant reliance" framing creates strategic urgency around financial sustainability.

DATA SOURCES:

HRSA UDS Reports - GRANT_REVENUE, MEDICAL_REVENUE, TOTAL_REVENUE, MEDICAID_PATIENTS, UNINSURED_PATIENTS fields
HRSA aggregate data for benchmark (median FQHC revenue mix ~55% medical, ~38% grant)
Confidence: 95% individual data, 90% benchmark

Subject: Grant dependency analysis You're at 52% grant revenue vs 38% median FQHC—that's $406k excess grant reliance. Your Medicaid/uninsured mix is 78%, but billing capture rate appears below benchmark. Worth reviewing payer-specific denial patterns?

CALCULATION WORKSHEET: CLAIM 1: "52% grant revenue vs 38% median FQHC" - Your data: $1,508,000 grant / $2,900,000 total = 52% - Benchmark: Median FQHC grant revenue ≈ 38% (from HRSA aggregates) - Confidence: 95% CLAIM 2: "$406k excess grant reliance" - Formula: (Your Grant % - Benchmark %) × Total Revenue - Calculation: (0.52 - 0.38) × $2,900,000 = $406,000 - Confidence: 85% CLAIM 3: "Medicaid/uninsured mix is 78%" - Source: UDS patient demographics - Formula: (MEDICAID_PATIENTS + UNINSURED_PATIENTS) / TOTAL_PATIENTS - Calculation: (1,523 + 685) / 2,832 = 78% - Confidence: 95% Verification: UDS Section 9A (Revenues) + Section 6B (Patient Demographics)

Buyer Critique Score: 8.0/10

Situation Recognition: 8/10 - Grant dependency + payer mix is strategically specific
Data Credibility: 9/10 - All UDS audited data
Insight Value: 8/10 - Connects grant dependency to billing capture (non-obvious)
Effort to Reply: 8/10 - "Worth reviewing?" is easy yes/no
Emotional Resonance: 7/10 - Strategic concern (grant sustainability)

Play #3: Revenue Benchmark Gap Good (7.8/10)

Target: FQHCs with medical revenue <45% of total revenue, significantly below the 55% median for similar health centers.

Why It Works: Benchmark comparison creates external validation—the prospect may know their revenue mix internally, but doesn't regularly compare themselves to peer FQHCs. The "$377k opportunity" quantifies the gap in concrete budget terms. Creates curiosity about root causes (denial rates? undercoding? slow collections?).

DATA SOURCES:

HRSA UDS Reports - Individual FQHC revenue data
HRSA aggregate benchmarks (median calculations across all FQHCs)
Confidence: 95% individual data, 90% benchmark

Subject: Your revenue benchmark Your medical revenue is 42% of total vs median FQHC at 55%. That's $377k annually you're leaving on the table at benchmark billing efficiency. Want the breakdown by payer?

CALCULATION WORKSHEET: CLAIM 1: "Your medical revenue is 42% of total" - Source: UDS Section 9A - Calculation: $1,218,000 / $2,900,000 = 42% - Confidence: 95% CLAIM 2: "median FQHC at 55%" - Source: HRSA aggregate UDS data (national benchmarks) - Method: Calculate median medical revenue % across all FQHCs - Confidence: 90% CLAIM 3: "$377k annually leaving on table" - Formula: (Total Revenue × Benchmark %) - Current Medical Revenue - Calculation: ($2,900,000 × 0.55) - $1,218,000 = $377,000 - Assumption: Benchmark efficiency is achievable - Confidence: 85% Verification: UDS Section 9A, compare to HRSA published benchmarks

Buyer Critique Score: 7.8/10

Situation Recognition: 8/10 - Benchmark comparison is specific and relevant
Data Credibility: 8/10 - UDS + benchmark credible
Insight Value: 7/10 - Benchmark useful, but needs HOW to close gap
Effort to Reply: 9/10 - Simple yes/no question
Emotional Resonance: 7/10 - $377k significant but feels theoretical without root cause

This play may benefit from additional data refinement (e.g., denial rate analysis, coding audit findings).

Play #4: Growth Bottleneck Detection Good (7.2/10)

Target: FQHCs with 15%+ patient growth but flat grant revenue percentage, suggesting claim processing can't keep pace with volume.

Why It Works: Identifies the gap between patient volume growth (18%) and revenue optimization. The prospect knows they're growing, but the specific connection to grant revenue stagnation creates a new lens: "We added 432 patients but didn't improve our revenue mix—are we dropping claims in the chaos?"

DATA SOURCES:

HRSA UDS Reports - Year-over-year patient counts and revenue mix
Confidence: 95% (government audited data)

Subject: 18% growth, 47 days Your UDS shows patient volume jumped 18% (2,400→2,832) last year while grant revenue stayed at 43%. That's 432 more patients without proportional medical revenue growth—suggests claim processing bottleneck. Does this match your A/R aging?

CALCULATION WORKSHEET: CLAIM 1: "patient volume jumped 18% (2,400→2,832)" - Source: UDS Section 5 (TOTAL_PATIENTS) - Calculation: (2,832 - 2,400) / 2,400 = 18% - Confidence: 95% CLAIM 2: "grant revenue stayed at 43%" - Source: UDS Section 9A (GRANT_REVENUE / TOTAL_REVENUE) - Calculation: Year-over-year comparison shows flat grant dependency - Confidence: 95% CLAIM 3: "432 more patients without proportional medical revenue growth" - Calculation: 2,832 - 2,400 = 432 patients - Inference: If grant % flat and volume +18%, medical revenue should also grow ~18% IF billing efficiency maintained. Flat/declining medical revenue % indicates bottleneck. - Confidence: 70% (inference layer) Verification: Compare UDS Section 5 and 9A year-over-year

Buyer Critique Score: 7.2/10

Situation Recognition: 7/10 - Growth + grant % specific but "47 days" in subject not explained
Data Credibility: 9/10 - UDS data verifiable
Insight Value: 6/10 - Growth→bottleneck connection somewhat obvious
Effort to Reply: 8/10 - Easy yes/no: "Does this match?"
Emotional Resonance: 6/10 - Mild curiosity, not urgent crisis

The Transformation

Traditional SDR outreach treats prospects like they're unaware of their own problems. Blueprint treats them like the experts they are—and offers them data syntheses they can't easily generate themselves.

The shift:

From "I noticed you're growing" → To "Your per-patient revenue dropped 11% despite 18% growth—that's $362k in efficiency loss"
From "We help with billing" → To "You're at 42% medical revenue vs 55% median—here's the exact gap"
From "Can we schedule 15 minutes?" → To "Does this match your A/R aging?"

This is the power of hard data: you earn the right to their attention by doing research they can't easily replicate.

Implementation Notes

Data Feasibility

All plays use HIGH feasibility data sources:

HRSA UDS Reports: Free API access (data.hrsa.gov), updated annually, fully audited
HRSA Aggregate Benchmarks: Available in public UDS summary reports
NPI Registry: Free API for provider counts and organizational validation

Target Volume

There are approximately 1,400 HRSA-funded FQHCs in the United States. Filtering to those with:

2,000-15,000 annual patients (excludes very small/very large)
Medical revenue <50% OR patient growth >12% Y/Y
Yields ~350-500 high-fit targets

Persona Targeting

Primary: Executive Director / CEO (financial sustainability, board reporting)

Secondary: CFO / Finance Director (revenue cycle, UDS reporting)

Tertiary: Chief Medical Officer (clinical operations + financial performance)

Timing Considerations

Q1 (Jan-Mar): Post-UDS submission, budget planning season (HIGH intent)
Q2 (Apr-Jun): HRSA site visit prep season, operational focus (MEDIUM intent)
Q3 (Jul-Sep): Mid-year budget reviews, potential EHR evaluation (MEDIUM intent)
Q4 (Oct-Dec): UDS data collection crunch, avoid outreach (LOW intent)

About Blueprint GTM

Blueprint GTM is a methodology and system for identifying prospects in verifiable pain using government regulatory data, competitive intelligence, and velocity signals. Unlike traditional demand generation that relies on growth proxies and generic messaging, Blueprint creates hyper-specific, non-obvious insights that earn replies.

This playbook was generated using the Blueprint Turbo system, which combines:

Automated data landscape discovery across government databases
AI-powered synthesis to identify non-obvious segment patterns
Buyer critique simulation (extended thinking) to validate message quality
Hard gate validation to ensure product-fit and data feasibility

Contact: Jordan Crawford | Blueprint GTM
Website: blueprintgtm.com